lisbon

BioGenCell’s clinical study PI, Dr. Mark Niven

BioGenCell’s clinical study PI, Dr. Mark Niven, a worldwide leader in the field of diabetes and the Director of the Endocrine and Diabetes Unit, incorporating the Bildirici Center for Diabetes Care and Research at Laniado Hospital, Israel, gave a scientific presentation of the company’s preliminary results at the 53rd annual meeting of the European Association for the Study of Diabetes, EASD held on the 11-15 of September in Lisbon, Portugal. The conference program can be seen on https://www.easd.org/annual-meeting/easd-2017.html#section-scientific-programme

Share this Article
Font Resize